November 22, 2010 | by Nobel Biocare
|
Reading time: 1 minute
November 22, 2010, Nobel Biocare announced today the extension of its existing EUR 330 million committed syndicated banking facility for 5 years (through 2015). Besides the extension, Nobel Biocare was able to improve the implied funding terms in the new facility, which was done with the same 6 international banks as with the original line.
Dirk Kirsten, Chief Financial Officer, said: “The amendment and extension of the existing line reflects Nobel Biocare's continued balance sheet strength and its ability to generate a positive cash flow even in a difficult economic environment. Furthermore, the facility also supports our financial flexibility going forward. I am pleased that the same 6 banks have reconfirmed their commitment for a longer period.”
Contact
Nobel Biocare Nicolas Weidmann Senior Vice President Global Communications T.: +41 43 211 42 80 M.: +41 79 372 29 81 E.: nicolas.weidmann@nobelbiocare.com
Editor's note: Image rights belong to the respective publisher.
Conclusion of this article: « Nobel Biocare extends syndicated loan facility »
Source: Nobel Biocare, Press release